The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
Open accessAbstract
Asthma is a complex, persistent, inflammatory disease characterised by airway hyperresponsiveness in association with airway inflammation. Studies suggest that regular use of high-dose inhaled corticosteroids and long-acting bronchodilators or omalizumab (a humanised monoclonal antibody that binds to immunoglobulin E and is often used as next-step therapy) may not be sufficient to provide asthma control in all patients, highlighting an important unmet need. Interleukin-4, interleukin-13, and the signal transducer and activator of transcription factor-6 are key components in the development of airway inflammation, mucus production, and airway hyperresponsiveness in asthma. Biological compounds targeting these molecules may provide a new therapeutic modality for patients with uncontrolled severe asthma. The purpose of this review is to summarise current studies of compounds targeting the interleukin-4/interleukin-13 pathway and to provide a rationale for the development of such compounds for this use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R., & Kay, A. B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260504 · Cited by 2,768
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Self-citationStat6 Is Required for Mediating Responses to IL-4 and for the Development of Th2 Cells
Kaplan, M. H., Schindler, U., Smiley, S. T., & Grusby, M. J. (1996) · Immunity · doi:10.1016/s1074-7613(00)80439-2 · Cited by 1,628
Can Guideline-defined Asthma Control Be Achieved?: The Gaining Optimal Asthma ControL Study
Bateman, E. D., Boushey, H. A., Bousquet, J., Busse, W. W., Clark, T. J. H., Pauwels, R. A., & Pedersen, S. E. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-033oc · Cited by 1,594
Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J., Beeh, K. ‐., Ramos, S., Canonica, G. W., Hedgecock, S., et al. (2005) · Allergy · doi:10.1111/j.1398-9995.2004.00772.x · Cited by 1,123
Kuperman, D. A., Huang, X., Koth, L. L., Chang, G. H., Dolganov, G. M., Zhu, Z., Elias, J. A., Sheppard, D., & Erle, D. J. (2002) · Nature Medicine · doi:10.1038/nm734 · Cited by 937
Hershey, G. K. K., Friedrich, M. F., Esswein, L. A., Thomas, M. L., & Chatila, T. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712113372403 · Cited by 748
Interleukin‐13 in asthma pathogenesis
Wills‐Karp, M. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00215.x · Cited by 683
Holcomb, I. N., Kabakoff, R. C., Chan, B., Baker, T. W., Gurney, A., Henzel, W., Nelson, C., Lowman, H. B., Wright, B. D., Skelton, N. J., et al. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4046 · Cited by 661
IL-13 receptors and signaling pathways: An evolving web
Hershey, G. K. K. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1333 · Cited by 610
Wenzel, S., Wilbraham, D., Fuller, R., Getz, E. B., & Longphre, M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61600-6 · Cited by 588
Kuperman, D., Schofield, B., Wills-Karp, M., & Grusby, M. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.939 · Cited by 446
Genetic variants of IL-13 signalling and human asthma and atopy
Heinzmann, A. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.4.549 · Cited by 424
Interleukin-4 Receptor in Moderate Atopic Asthma: A Phase I/II Randomized, Placebo-controlled Trial
BORISH, L. C., NELSON, H. S., LANZ, M. J., CLAUSSEN, L., WHITMORE, J. B., AGOSTI, J. M., & GARRISON, L. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9808146 · Cited by 418
Efficacy of soluble IL-4 receptor for the treatment of adults with asthma
Borish, L. C., Nelson, H. S., Corren, J., Bensch, G., Busse, W. W., Whitmore, J. B., & Agosti, J. M. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.115624 · Cited by 411
Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity
Walter, D. M., McIntire, J. J., Berry, G., McKenzie, A. N. J., Donaldson, D. D., DeKruyff, R. H., & Umetsu, D. T. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4668 · Cited by 396
Ile50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma
Mitsuyasu, H., Izuhara, K., Mao, X.-Q., Gao, P.-S., Arinobu, Y., Enomoto, T., Kawai, M., Sasaki, S., Dake, Y., Hamasaki, N., et al. (1998) · Nature Genetics · doi:10.1038/472 · Cited by 358
Rankin, J. A., Picarella, D. E., Geba, G. P., Temann, U. A., Prasad, B., DiCosmo, B., Tarallo, A., Stripp, B., Whitsett, J., & Flavell, R. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7821 · Cited by 344
Self-citationIL-13 induces eosinophil recruitment into the lung by an IL-5– and eotaxin-dependent mechanism
Pope, S. M., Brandt, E. B., Mishra, A., Hogan, S. P., Zimmermann, N., Matthaei, K. I., Foster, P. S., & Rothenberg, M. E. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118600 · Cited by 314
Signaling mechanisms, interaction partners, and target genes of STAT6
HEBENSTREIT, D., WIRNSBERGER, G., HOREJSHOECK, J., & DUSCHL, A. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.01.004 · Cited by 308
Lanone, S., Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Ma, B., Chen, Q., Homer, R. J., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14136 · Cited by 299
A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
Corren, J., Busse, W., Meltzer, E. O., Mansfield, L., Bensch, G., Fahrenholz, J., Wenzel, S. E., Chon, Y., Dunn, M., Weng, H. H., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1448oc · Cited by 299
Atopy and asthma: genetic variants of IL-4 and IL-13 signalling
Shirakawa, T., Deichmann, K. A., Izuhara, K., Mao, X.-Q., Adra, C. N., & Hopkin, J. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01492-9 · Cited by 279
Untangling the Complex Web of IL-4– and IL-13–Mediated Signaling Pathways
Wills-Karp, M., & Finkelman, F. D. (2008) · Science Signaling · doi:10.1126/scisignal.1.51.pe55 · Cited by 274
Mattes, J., Yang, M., Mahalingam, S., Kuehr, J., Webb, D. C., Simson, L., Hogan, S. P., Koskinen, A., McKenzie, A. N. J., Dent, L. A., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020009 · Cited by 264
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
Saha, S. K., Berry, M. A., Parker, D., Siddiqui, S., Morgan, A., May, R., Monk, P., Bradding, P., Wardlaw, A. J., Pavord, I. D., et al. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.01.005 · Cited by 255
Activation of eotaxin gene transcription by NF-kappa B and STAT6 in human airway epithelial cells.
Matsukura, S., Stellato, C., Plitt, J. R., Bickel, C., Miura, K., Georas, S. N., Casolaro, V., & Schleimer, R. P. (1999) · PubMed · Cited by 236
Zurawski, S. M., Chomarat, P., Djossou, O., Bidaud, C., McKenzie, A. N. J., Miossec, P., Banchereau, J., & Zurawski, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13869 · Cited by 227
Association studies for asthma and atopic diseases: a comprehensive review of the literature
Hoffjan, S., Nicolae, D., & Ober, C. (2003) · Respiratory Research · doi:10.1186/1465-9921-4-14 · Cited by 220
Kawakami, K., Taguchi, J., Murata, T., & Puri, R. K. (2001) · Blood · doi:10.1182/blood.v97.9.2673 · Cited by 218
Brightling, C. E., Symon, F. A., Birring, S. S., Bradding, P., Pavord, I. D., & Wardlaw, A. J. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.129698 · Cited by 217
Miloux, B., Laurent, P., Bonnin, O., Lupker, J., Caput, D., Vita, N., & Ferrara, P. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01462-7 · Cited by 214
Activation of Eotaxin Gene Transcription by NF-κB and STAT6 in Human Airway Epithelial Cells
Matsukura, S., Stellato, C., Plitt, J. R., Bickel, C., Miura, K., Georas, S. N., Casolaro, V., & Schleimer, R. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6876 · Cited by 195
Yang, G., Volk, A., Petley, T., Emmell, E., Giles-Komar, J., Shang, X., Li, J., Das, A. M., Shealy, D., Griswold, D. E., et al. (2004) · Cytokine · doi:10.1016/j.cyto.2004.08.007 · Cited by 192
Constitutive and Cytokine-Stimulated Expression of Eotaxin by Human Airway Smooth Muscle Cells
GHAFFAR, O., HAMID, Q., RENZI, P. M., ALLAKHVERDI, Z., MOLET, S., HOGG, J. C., SHORE, S. A., LUSTER, A. D., & LAMKHIOUED, B. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9805039 · Cited by 191
Vladich, F. D., Brazille, S. M., Stern, D., Peck, M. L., Ghittoni, R., & Vercelli, D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522818 · Cited by 182
Blanchard, C., Mishra, A., Saito‐Akei, H., Monk, P., Anderson, I., & Rothenberg, M. E. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02299.x · Cited by 181
Mathew, A., MacLean, J. A., DeHaan, E., Tager, A. M., Green, F. H. Y., & Luster, A. D. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1087 · Cited by 179
Matsukura, S., Stellato, C., Georas, S. N., Casolaro, V., Plitt, J. R., Miura, K., Kurosawa, S., Schindler, U., & Schleimer, R. P. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4351 · Cited by 169
Andrews, A.-L., Holloway, J. W., Holgate, S. T., & Davies, D. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7456 · Cited by 162
Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis
Berry, M. A., Parker, D., Neale, N., Woodman, L. B., Morgan, A. J., Monk, P., Bradding, P. H., Wardlaw, A. J., Pavord, I. D., & Brightling, C. E. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.032 · Cited by 155
Therapeutic Effect of IL-13 Immunoneutralization During Chronic Experimental Fungal Asthma
Blease, K., Jakubzick, C., Westwick, J. K., Lukacs, N. W., Kunkel, S. L., & Hogaboam, C. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5219 · Cited by 148
Interleukin-13 Signal Transduction in Lymphohemopoietic Cells
Welham, M. J., Learmonth, L., Bone, H. K., & Schrader, J. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.12286 · Cited by 144
Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma
Arima, K., Suyama, R., Sakata, Y., Akaiwa, M., Mao, X., Enomoto, T., Dake, Y., Shimazu, S.-I., Yamashita, T., Sugawara, N., et al. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.124656 · Cited by 144
Brightling, C. E., Symon, F. A., Holgate, S. T., Wardlaw, A. J., Pavord, I. D., & Bradding, P. H. (2003) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2003.01827.x · Cited by 143
IL-4 induces IL-13–independent allergic airway inflammation
Perkins, C. L., Wills-Karp, M. A., & Finkelman, F. D. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.06.004 · Cited by 119
Therapeutic Targeting of IL-4- and IL-13-Responsive Cells in Pulmonary Fibrosis
Jakubzick, C., Kunkel, S. L., Puri, R. K., & Hogaboam, C. M. (2004) · Immunologic Research · doi:10.1385/ir:30:3:339 · Cited by 118
Blease, K., Schuh, J. M., Jakubzick, C., Lukacs, N. W., Kunkel, S. L., Joshi, B. H., Puri, R. K., Kaplan, M. H., & Hogaboam, C. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64867-5 · Cited by 116
Recent advances in asthma genetics
Zhang, J., Paré, P. D., & Sandford, A. J. (2008) · Respiratory Research · doi:10.1186/1465-9921-9-4 · Cited by 102
McCusker, C. T., Wang, Y., Shan, J., Kinyanjui, M. W., Villeneuve, A., Michael, H., & Fixman, E. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2556 · Cited by 96
Chibana, K., Ishii, Y., Asakura, T., & Fukuda, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4290 · Cited by 76
Jakubzick, C., Choi, E. S., Carpenter, K. J., Kunkel, S. L., Evanoff, H. L., Martínez, F. J., Flaherty, K. R., Toews, G. B., Colby, T. V., Travis, W. D., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63759-5 · Cited by 76
Hoshino, A. (2004) · International Immunology · doi:10.1093/intimm/dxh151 · Cited by 74
IL-13 blockade reduces lung inflammation after Ascaris suum challenge in cynomolgus monkeys
Bree, A. G., Schlerman, F. J., Wadanoli, M. D., Tchistiakova, L., Marquette, K., Tan, X., Jacobson, B. A., Widom, A., Cook, T. A., Wood, N., et al. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.02.009 · Cited by 72
IL-13 receptor isoforms: Breaking through the complexity
Tabata, Y., & Hershey, G. K. K. (2007) · Current Allergy and Asthma Reports · doi:10.1007/s11882-007-0051-x · Cited by 71
Reassessing the Th2 cytokine basis of asthma
O’Byrne, P. M., Inman, M. D., & Adelroth, E. C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.008 · Cited by 62
The gene encoding interleukin-13: a susceptibility locus for asthma and related traits
Wills-Karp, M. A. (2000) · Respiratory Research · doi:10.1186/rr7 · Cited by 52
Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia
Jakubzick, C., Choi, E. S., Kunkel, S. L., Evanoff, H. L., Martinez, F. J., Puri, R. K., Flaherty, K. R., Toews, G. B., Colby, T. V., Kazerooni, E. A., et al. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.012799 · Cited by 52
Madhankumar, A. B., Mintz, A., & Debinski, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205047200 · Cited by 50
Lanone, S., Zheng, T., Zhu, Z., Liu, W. Y., Lee, C. G., Ma, B., Chen, Q., Homer, R., Wang, J., Rabach, L. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214136 · Cited by 50
Creating the next generation of protein therapeutics through rational drug design.
Szymkowski, D. E. (2005) · PubMed · Cited by 40
Effect of IL-13 receptor α2 levels on the biological activity of IL-13 variant R110Q
Andrews, A.-L., Bucchieri, F., Arima, K., Izuhara, K., Holgate, S. T., Davies, D. E., & Holloway, J. W. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.026 · Cited by 30
Ohga, K., Kuromitsu, S., Takezawa, R., Numazaki, M., Ishikawa, J., Nagashima, S., & Shimizu, Y. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.035 · Cited by 23
Cited by
Targeting key proximal drivers of type 2 inflammation in disease
Gandhi, N. A., Bennett, B. L., Graham, N. M. H., Pirozzi, G., Stahl, N., & Yancopoulos, G. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd4624 · Cited by 766
Type 2 cytokines: mechanisms and therapeutic strategies
Wynn, T. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3831 · Cited by 678
Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
Jia, G., Erickson, R. W., Choy, D. F., Mosesova, S., Wu, L. C., Solberg, O. D., Shikotra, A., Carter, R., Audusseau, S., Hamid, Q., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.06.025 · Cited by 615
Commonality of the IL-4/IL-13 pathway in atopic diseases
Gandhi, N. A., Pirozzi, G., & Graham, N. M. H. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1298443 · Cited by 493
Pathophysiology of allergic inflammation
Barnes, P. J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01020.x · Cited by 361
Metadata
- Authors
- Oh, C. K., Geba, G. P., & Molfino, N.
- Venue
- European Respiratory Review
- Publisher
- European Respiratory Society (ERS)
- Published
- 2010-02-28
- Volume
- 19
- Issue
- 115
- Pages
- 46-54
- ISSN
- 0905-9180 (ISSN-L)
- 1600-0617
- OpenAlex
- W2171449633
- Cited by
- 256
- References
- 66
- FWCI
- 11.98
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.